IL22 and colitis: Importantly, decreased IL-18, and to a lesser extent IFNγ, production was evident in Casp11−/− mice at 2 weeks (Fig. 3k, l), which may be ultimately responsible for defective IL-22 production observed in these mice during both experimental colitis and CAC [43].